2-42245660-T-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM1BP4_StrongBS2
The NM_019063.5(EML4):c.181T>A(p.Ser61Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000652 in 1,609,970 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_019063.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EML4 | NM_019063.5 | c.181T>A | p.Ser61Thr | missense_variant | 2/23 | ENST00000318522.10 | NP_061936.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EML4 | ENST00000318522.10 | c.181T>A | p.Ser61Thr | missense_variant | 2/23 | 1 | NM_019063.5 | ENSP00000320663.5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152134Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000133 AC: 33AN: 247536Hom.: 0 AF XY: 0.000172 AC XY: 23AN XY: 133614
GnomAD4 exome AF: 0.0000707 AC: 103AN: 1457836Hom.: 2 Cov.: 31 AF XY: 0.0000979 AC XY: 71AN XY: 725008
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152134Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2024 | The c.181T>A (p.S61T) alteration is located in exon 2 (coding exon 2) of the EML4 gene. This alteration results from a T to A substitution at nucleotide position 181, causing the serine (S) at amino acid position 61 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at